Mary Woolley Weekly Advocacy Messages
I am pleased to repeat myself when I report that it’s been another science-heavy week on Capitol Hill...and most, but not all, of the news is good.
The House Energy and Commerce Health subcommittee considered the next draft of the 21st Century Cures legislation this morning.
Later today, I will participate on a panel at Aspen Ideas: Health to explore the implications of an ambitious new survey commissioned by the Wellcome Trust.
The House is working to reach its goal of passing all twelve FY20 appropriations bills by the end of June; today's briefing on the Bayh-Dole Act.
Yesterday, the Administration announced that an NIH fetal tissue research-related contract with UCSF will not be renewed; intramural researchers at NIH will no longer be able to procure fetal tissue for research; and another layer of review will be imposed on all those seeking federal funding for fetal tissue research.
At our recent jam-packed Alliance Member Meeting we heard from Grace Graham, Health Policy Director for Senate HELP Committee Chairman Alexander (R-TN), and Andi Fristedt, Deputy Health Policy Director for Ranking Member Murray (D-WA).
Negotiations on raising the budget caps will reportedly resume when Congress returns from a week-long break.
The House Labor-HHS Appropriations Subcommittee markup of Fiscal Year 2020 spending priorities on Tuesday featured lots of good news.
When members of Congress return to Washington, D.C. next week, the House will begin considering Fiscal Year (FY) 2020 appropriations bills, with the Labor-HHS Subcommittee scheduled to mark up their bill on April 30.
Dear Research Advocate,